TNYA Company Profile and Key Details

Q: Who are the executives of TNYA?

Dr. Saptarsi Haldar M.D.Scientific FounderDr. Sheng DingScientific FounderDr. Kee-Hong Kim Ph.D.Chief Technology OfficerMr. Faraz Ali M.B.A.Chief Executive Officer, Sec. & DirectorDr. Deepak Srivastava M.D.Scientific Founder, Chairman of Scientific Advisory Board & DirectorDr. Whittemore G. Tingley M.D., PH.D.Chief Medical OfficerDr. Benoit G. Bruneau Ph.D.Scientific FounderDr. Eric N. Olson Ph.D.Co-Founder & Chairman of Scientific Advisory BoardDr. Bruce R. ConklinScientific FounderDr. Timothy Hoey Ph.D.Chief Scientific OfficerMs. Leone D. Patterson M.B.A.Chief Financial & Bus. Officer

NASDAQ : TNYA

Tenaya Therapeutics

$0.88

-0.0401-4.36%

At Close 4:00 PM

63.43

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Tenaya Therapeutics, Inc. (TNYA) stock declined over -4.36%, trading at $0.88 on NASDAQ, down from the previous close of $0.92. The stock opened at $0.86, fluctuating between $0.85 and $0.92 in the recent session.

Stock Snapshot

0.92

Prev. Close

146.59M

Market Cap

0.85

Day Low

-1.87

P/E Ratio

-0.47

EPS (TTM)

-1.51

Cash Flow per Share

0.86

Open

166.6M

Number of Shares

0.92

Day High

93.57%

Free Float in %

2.04

Book Value

3.87M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 08, 2026	0.88	0.92	0.84	0.88	3.88M
Jul 07, 2026	0.86	0.94	0.84	0.92	6.08M
Jul 06, 2026	0.79	0.92	0.78	0.87	7.06M
Jul 02, 2026	0.74	0.80	0.74	0.79	2.16M
Jul 01, 2026	0.74	0.75	0.72	0.75	1.24M
Jun 30, 2026	0.75	0.75	0.72	0.74	989.04K
Jun 29, 2026	0.74	0.75	0.71	0.73	1.61M
Jun 26, 2026	0.70	0.74	0.70	0.72	1.2M
Jun 25, 2026	0.72	0.75	0.71	0.71	1.29M
Jun 24, 2026	0.73	0.78	0.73	0.73	1.85M
Jun 23, 2026	0.70	0.75	0.69	0.73	2.41M
Jun 22, 2026	0.72	0.74	0.70	0.70	2.03M
Jun 18, 2026	0.71	0.74	0.69	0.73	2.49M
Jun 17, 2026	0.70	0.74	0.69	0.71	2.97M
Jun 16, 2026	0.72	0.72	0.68	0.68	3.45M
Jun 15, 2026	0.74	0.74	0.71	0.72	2.11M
Jun 12, 2026	0.70	0.73	0.70	0.71	1.39M
Jun 11, 2026	0.70	0.72	0.68	0.72	2.9M
Jun 10, 2026	0.70	0.74	0.69	0.70	2.03M
Jun 09, 2026	0.70	0.74	0.68	0.71	2.77M

Contact Details

South San Francisco, CA 94080

United States

https://www.tenayatherapeutics.com 650 825 6900

About Company

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Stock Peers

ARGX

-4.64-0.50%

argenx SE$915.30 REGN

-13.35-1.97%

Regeneron Pharmaceuticals, Inc.$662.88 MDGL

20.04+3.67%

Madrigal Pharmaceuticals, Inc.$565.40 UTHR

-9.36-1.66%

United Therapeutics Corporation$554.34 VRTX

-23.82-4.56%

Vertex Pharmaceuticals Incorporated$498.43 KRYS

6.8+1.84%

Krystal Biotech, Inc.$375.40 PRAX

9.04+2.79%

Praxis Precision Medicines, Inc.$332.99 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.91+0.59%

Alnylam Pharmaceuticals, Inc.$323.50 LGND

-4.55-1.42%

Ligand Pharmaceuticals Incorporated$314.88

Frequently Asked Questions

What is the current Tenaya Therapeutics, Inc. (TNYA) stock price?

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) stock price is $0.88 in the last trading session. During the trading session, TNYA stock reached the peak price of $0.92 while $0.85 was the lowest point it dropped to. The percentage change in TNYA stock occurred in the recent session was -4.36% while the dollar amount for the price change in TNYA stock was - $0.04.

TNYA's industry and sector of operation?

The NASDAQ listed TNYA is part of Biotechnology industry that operates in the broader Healthcare sector. Tenaya Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TNYA?

Dr. Saptarsi Haldar M.D.
Scientific Founder
Dr. Sheng Ding
Scientific Founder
Dr. Kee-Hong Kim Ph.D.
Chief Technology Officer
Mr. Faraz Ali M.B.A.
Chief Executive Officer, Sec. & Director
Dr. Deepak Srivastava M.D.
Scientific Founder, Chairman of Scientific Advisory Board & Director
Dr. Whittemore G. Tingley M.D., PH.D.
Chief Medical Officer
Dr. Benoit G. Bruneau Ph.D.
Scientific Founder
Dr. Eric N. Olson Ph.D.
Co-Founder & Chairman of Scientific Advisory Board
Dr. Bruce R. Conklin
Scientific Founder
Dr. Timothy Hoey Ph.D.
Chief Scientific Officer
Ms. Leone D. Patterson M.B.A.
Chief Financial & Bus. Officer

How TNYA did perform over past 52-week?

TNYA's closing price is 65.39% higher than its 52-week low of $0.53 where as its distance from 52-week high of $2.35 is -62.56%.

How many employees does TNYA have?

Number of TNYA employees currently stands at 70.

Link for TNYA official website?

Official Website of TNYA is: https://www.tenayatherapeutics.com

How do I contact TNYA?

TNYA could be contacted at phone 650 825 6900 and can also be accessed through its website. TNYA operates from 171 Oyster Point Boulevard, South San Francisco, CA 94080, United States.

How many shares of TNYA are traded daily?

TNYA stock volume for the day was 3.87M shares. The average number of TNYA shares traded daily for last 3 months was 3.74M.

What is the market cap of TNYA currently?

The market value of TNYA currently stands at $146.59M with its latest stock price at $0.88 and 166.6M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	70
Beta	2.82
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	70
Beta	2.82
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

TNYA Company Profile and Key Details

Tenaya Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook